Gates Foundation Strategic Investment Fund Logo
>
Share this page:

Press Release: Tiantan Biological Products receives financial backing from Bill & Melinda Gates Foundation

Research in China

November 16, 2011

Beijing Tiantan Biological Products (600161.SH) plans to sign financial aid, loan and unilateral guarantee agreements with the Bill & Melinda Gates Foundation to develop oral polio vaccines (OPV), reports stcn.com, citing a company filing.

Read the full text here.